HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use Azithromycin safely and effectively. See full prescribing information for Azithromycin.
AZITHROMYCIN for injection, for intravenous use
Initial U.S. Approval: 2009
RECENT MAJOR CHANGES
INDICATIONS AND USAGE
Azithromycin is a macrolide antibacterial drug indicated for mild to moderate infections caused by designated, susceptible bacteria:
To reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin and other antibacterial drugs, azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. (1.3)
DOSAGE AND ADMINISTRATION
DOSAGE FORMS AND STRENGTHS
Azithromycin for Injection is supplied as white to off-white lyophilized powder in a single-dose ADD-Vantage® vial equivalent to 500 mg of azithromycin for intravenous administration. (3)
WARNINGS AND PRECAUTIONS
Most common adverse reactions are nausea (4%), diarrhea (4%), abdominal pain (3%), or vomiting (1%). (6)
To report SUSPECTED ADVERSE REACTIONS, contact Hospira, Inc. at 1-800-441-4100, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
USE IN SPECIFIC POPULATIONS
See 17 for PATIENT COUNSELING INFORMATION.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.